Zhenghai Biotechnology Co., Ltd.
正海生物
300653
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on Completion of Renewal Registration for Medical Device Products
Announcement on the implementation of the 2025 annual equity distribution
Announcement on participating in the 2026 online collective reception day for investors of listed companies in Shandong Province
Legal opinion letter from Shandong Chuanqi Law Firm regarding the annual general meeting of shareholders of Yantai Zhenghai Biotechnology Co., Ltd. in 2025
Announcement of the resolutions of the annual general meeting of shareholders in 2025
Reminder Announcement on the 2025 Annual Shareholders' Meeting
Announcement on Changes in Accounting Policies
Announcement of Resolutions from the Eleventh Meeting of the Fourth Board of Directors
Q1 2026 Report
Announcement on the progress of using idle self-owned funds for cash management
Announcement on the reduction of shares by shareholders holding more than 5% reaching an integer multiple of 1%
Announcement Regarding the Re-appointment of the 2026 Annual Audit Firm
Announcement Regarding the 2026 Compensation Plan for Directors and Senior Management
2025 Annual Financial Final Account Report
2025 Annual Board of Directors' Work Report
Audit Committee's Review Opinion on the Company's 2025 Annual Internal Control Evaluation Report
Announcement Regarding the Purchase of Directors' and Senior Management's Liability Insurance
2025 Annual Independent Director's Performance Report (Wang Hui)
2025 Annual Independent Director's Performance Report (Song Xiliang)
2025 Annual Independent Director's Performance Report (Li Jianghua)
Announcement Regarding the Holding of the 2025 Annual Online Performance Briefing
2025 Annual Corporate Social Responsibility Report
Internal Control Audit Report
2025 Internal Control Evaluation Report
Director Compensation and Performance Management System
External Investment Management System
Raised Funds Management System
Senior Management Compensation and Performance Management System
Investor Relations Management System
Notice of Convening the 2025 Annual General Meeting of Shareholders
Resolution Announcement of the 10th Meeting of the Fourth Board of Directors
Announcement Regarding the 2025 Annual Profit Distribution Plan
Audit Committee's Assessment Report on the Accounting Firm's Performance of Duties
Audit Committee's Report on the Supervision of the Accounting Firm's Performance of Duties
Special Explanation on Fund Occupancy by Controlling Shareholder and Other Related Parties
2025 Annual Summary Table of Non-Operating Fund Occupancy and Other Related Party Fund Transactions
Board of Directors' Special Opinion on the Independence Assessment of Independent Directors
2025 Annual Audit Report
2025 Annual Report
2025 Annual Report Summary
Announcement Regarding the 'Quality and Return Dual Enhancement' Action Plan
Announcement Regarding the Use of Idle Self-Owned Funds for Cash Management and Entrusted Wealth Management
Announcement of Pre-disclosure of Share Reduction by Shareholders Holding More Than 5% of Shares
Notes & Comments
Sign in to leave a comment or private note.
Loading…